Details for Patent: 7,056,886
✉ Email this page to a colleague
Summary for Patent: 7,056,886
Title: | GLP-2 formulations |
Abstract: | The invention is directed to formulations of GLP-2 peptides and analogs thereof exhibiting superior stability following storage and/or exposure to elevated temperatures. The GLP-2 compositions comprise a GLP-2 peptide or an analog thereof, a phosphate buffer, L-histidine, and mannitol. |
Inventor(s): | Isaacs; Indu J. (Andover, MA) |
Assignee: | NPS Allelix, Corp. (Mississauga, CA) |
Application Number: | 09/750,022 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 7,056,886 |
Patent Claim Types: see list of patent claims | Formulation; Process; Use; Device; |
Drugs Protected by US Patent 7,056,886
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 7,056,886
Foriegn Application Priority Data | ||
Foreign Country | Foreign Patent Number | Foreign Patent Date |
United Kingdom | 9930882 | Dec 30, 1999 |
International Family Members for US Patent 7,056,886
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Austria | 353665 | ⤷ Try a Trial | |||
Australia | 2462601 | ⤷ Try a Trial | |||
Australia | 782110 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |